A test measuring proteins in spinal fluid may help support the diagnosis of MS, especially in patients whose disease is harder to diagnose.

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

A new AI-powered cerebrospinal fluid liquid biopsy accurately classifies brain tumours using tiny DNA fragments. Learn more.

Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children PURPOSE: Leptomeningeal disease (LMD) significantly affects the prognosis and treatment of ...